Sacituzumab Govitecan Plus EV in Metastatic UC

Clinical trial NCT04724018 · RECRUITING

Trial details

NCT number: NCT04724018
Sponsor: Dana-Farber Cancer Institute
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Urothelial Cancer Metastatic Urothelial Carcinoma Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter Bladder Cancer

Start date: 2021-05-20
Primary completion: 2027-02-01
Enrollment: 106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.